Patents by Inventor Bapi Sarker

Bapi Sarker has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11884934
    Abstract: Among the various aspects of the present disclosure is the provision of methods, synthetic DC, and compositions for T cell activation. The present disclosure provides for synthetic dendritic cells (DCs), methods of generating synthetic dendritic cells (DCs), methods of generating T cell-encapsulated gelatin microspheres and microcapsules, methods of activating T cells using synthetic DCs, methods for expanding T cells against individualized antigen-specific mutational antigens using synthetic DCs, and methods of treating a chronic disease (e.g., HIV, HPV) or cancer using the synthetic DCs.
    Type: Grant
    Filed: July 20, 2018
    Date of Patent: January 30, 2024
    Assignee: Washington University
    Inventors: Eynav Klechevsky, Amit Pathak, Bapi Sarker
  • Patent number: 11697793
    Abstract: Among the various aspects of the present disclosure is the provision of a hydrogel-based substrate comprising an aldehyde-containing component, such as N-ethanal acrylamide. The hydrogel component allows for functionalization of a hydrogel through conjugation of proteins (e.g., collagen) to the hydrogel in the absence of a post hoc crosslinking component.
    Type: Grant
    Filed: October 10, 2019
    Date of Patent: July 11, 2023
    Assignee: Washington University
    Inventors: Amit Pathak, Bapi Sarker
  • Publication number: 20210163894
    Abstract: Among the various aspects of the present disclosure is the provision of methods, synthetic DC, and compositions for T cell activation. The present disclosure provides for synthetic dendritic cells (DCs), methods of generating synthetic dendritic cells (DCs), methods of generating T cell-encapsulated gelatin microspheres and microcapsules, methods of activating T cells using synthetic DCs, methods for expanding T cells against individualized antigen-specific mutational antigens using synthetic DCs, and methods of treating a chronic disease (e.g., HIV, HPV) or cancer using the synthetic DCs.
    Type: Application
    Filed: July 20, 2018
    Publication date: June 3, 2021
    Applicant: Washington University
    Inventors: Eynav KLECHEVSKY, Amit PATHAK, Bapi SARKER
  • Publication number: 20200115675
    Abstract: Among the various aspects of the present disclosure is the provision of a hydrogel-based substrate comprising an aldehyde-containing component, such as N-ethanal acrylamide. The hydrogel component allows for functionalization of a hydrogel through conjugation of proteins (e.g., collagen) to the hydrogel in the absence of a post hoc crosslinking component.
    Type: Application
    Filed: October 10, 2019
    Publication date: April 16, 2020
    Applicant: Washington University
    Inventors: Amit Pathak, Bapi Sarker
  • Publication number: 20180105793
    Abstract: Among the various aspects of the present disclosure is the provision of a device with multiple microenvironments and methods of use and manufacture thereof. An aspect of the present disclosure provides for a device for evaluating cell invasion. Another aspect provided by the present disclosure includes a method of making a device for evaluating cell invasion. Another aspect to the present disclosure provides for a method of testing a drug in vitro. Another aspect of the present disclosure provides for a method of identifying targets.
    Type: Application
    Filed: October 11, 2017
    Publication date: April 19, 2018
    Applicant: WASHINGTON UNIVERSITY
    Inventors: Amit Pathak, Samila Nasrollahi, Bapi Sarker